Thymosin Alpha-1
- 99%+ HPLC Purity — Independently verified by accredited US laboratory
- Endotoxin-Screened — LAL tested, LPS-free, endotoxin report available
- GMP-Certified Manufacturing — USA facility, ISO 9001:2015
- Lyophilized for Stability — Shipped cold-packed, intact for reconstitution
Add essential supplies:
For laboratory research use only. Not for human or veterinary use.
About Thymosin Alpha-1
Thymosin Alpha-1 is a 28-amino-acid peptide fragment derived from prothymosin alpha. It is supplied here as a lyophilized powder at 99%+ HPLC purity for laboratory research use only.
This material is a research chemical. It is not a medicine, is not for human or veterinary use, and no dosing, administration or clinical guidance is provided.
What is Thymosin Alpha-1?
Thymosin Alpha-1 is a synthetic version of a peptide originally isolated from thymic tissue. It is one of the most frequently cited reference peptides in immune-signalling research.
- T-cell research target: studied in vitro for its role in T-cell differentiation and maturation assays.
- Innate and adaptive models: referenced in literature examining signalling between immediate and memory immune responses.
- Modulatory profile: described in published receptor and cytokine studies as an immune modulator rather than a broad stimulant.
Published research context
The following summarises third-party laboratory and clinical literature about the molecule. It describes research conducted by others and is not a claim about this product, which is supplied for research use only.
Antiviral research
Thymosin Alpha-1 has been investigated in published studies of viral hepatitis and respiratory viral infection models.
Cellular immunity assays
In-vitro work has measured natural killer cell and macrophage activity in the presence of the peptide.
Vaccine adjuvant studies
Published research has evaluated the peptide as an adjuvant in antibody-response models.
Oncology adjunct literature
Clinical literature from third parties has examined the peptide alongside chemotherapy in immune-function studies.
Why researchers select this material
Laboratory handling characteristics reported for this compound:
- Extensive published literature base supporting protocol comparison and assay design.
- Well-characterised sequence and molecular weight for analytical verification.
- Supplied at 99%+ HPLC purity with published batch documentation.
- Stable lyophilized format under recommended cold storage.
Frequently Asked Questions
Thymosin Alpha-1 5mg: specification and research context
Thymosin Alpha-1 is a 28-amino-acid peptide fragment derived from prothymosin alpha, CAS 62304-98-7, molecular formula C₁₂₉H₂₁₅N₃₃O₅₅ at 3108.3 g/mol. The listed configuration is a 5mg lyophilized vial at 99%+ purity; larger mg options and vial tiers change the displayed price above.
Thymosin Alpha-1 is widely characterised in immunology literature for its role in T-cell differentiation assays and immune signalling models. Those references describe published laboratory and clinical research conducted by third parties; they are not claims about this material, which is supplied for research only.
This vial is a research chemical. It is not a medicine, is not for human or veterinary use, and no dosing, administration or clinical guidance is offered.
- Strength: 5mg vial (additional mg options available)
- Purity: 99%+ HPLC · Reference LPTA1-01
- CAS 62304-98-7 · C₁₂₉H₂₁₅N₃₃O₅₅ · 3108.3 g/mol
- Form: lyophilized powder — research use only
Review the matching batch documentation in our HPLC testing library, compare strengths across the independently tested research peptide catalog, or ask about volume pricing on the bulk offers page.
